BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochemical Pharmacology

• Publication date

  2000-04-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(99)00418-9PMID 10692558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death.

  1998influential reference
• Reactive Oxygen Species Released from Mitochondria during Brief Hypoxia Induce Preconditioning in Cardiomyocytes*

  1998cited by this paper
• Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.

  1998cited by this paper
• PEROXYNITRITE‐MEDIATED DNA STRAND BREAKAGE ACTIVATES POLY(ADP‐RIBOSE) SYNTHETASE AND CAUSES CELLULAR ENERGY DEPLETION IN A NONSEPTIC SHOCK MODEL INDUCED BY ZYMOSAN IN THE RAT

  1998cited by this paper
• The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy.

  1998cited by this paper
• Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.

  1998cited by this paper
• Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase.

  1998cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.

  1997influential reference
• Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.

  1997cited by this paper
• Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

  1996cited by this paper
• Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase.

  1996cited by this paper
• Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite.

  1996cited by this paper
• Myocardial Adaptive Changes and Damage in Ischemic Heart Disease

  1996cited by this paper
• Modulation of Superoxide-dependent Oxidation and Hydroxylation Reactions by Nitric Oxide (*)

  1996cited by this paper
• DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite.

  1996cited by this paper
• Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo.

  1995cited by this paper
• Metabolism of [3-13C]pyruvate and [3-13C]propionate in normal and ischaemic rat heart in vivo: 1H- and 13C-NMR studies.

  1995cited by this paper
• The role of lipid peroxidation in menadione-mediated toxicity in cardiomyocytes.

  1995cited by this paper
• Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

  1995cited by this paper
• Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells

  1995cited by this paper
• Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks.

  1995cited by this paper
• Role of ascorbate in protection by nitecapone against cardiac ischemia-reperfusion injury.

  1995cited by this paper
• Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.

  1994cited by this paper
• Lipoamide influences substrate selection in post-ischaemic perfused rat hearts.

  1994cited by this paper
• Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion.

  1994cited by this paper
• An alpha-tocopherol analogue with antioxidant activity improves myocardial function during ischemia reperfusion in isolated working rat hearts.

  1994cited by this paper
• ADP-ribosylation of the molecular chaperone GRP78/BiP

  1994cited by this paper
• The interaction of acteoside with mitochondrial lipid peroxidation as an ischemia/reperfusion injury model.

  1994cited by this paper
• An α-tocopherol analogue with antioxydant activity improves myocardial function during ischemia reperfusion in isolated working rat hearts

  1993cited by this paper
• Free radical scavenging enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium.

  1993cited by this paper
• Oxidative damage to mitochondria is mediated by the Ca(2+)-dependent inner-membrane permeability transition.

  1993cited by this paper
• Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow.

  1993cited by this paper
• Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells.

  1993cited by this paper
• Roles for oxidative stress and poly(ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methanesulfonate.

  1993cited by this paper
• Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart.

  1992cited by this paper
• Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.

  1991cited by this paper
• Effect of antiarrhythmic drugs on the postischaemic metabolic recovery of isolated rat hearts.

  1991cited by this paper
• Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues.

  1991cited by this paper
• Reversible ADP‐ribosylation of the 78 kDa glucose‐regulated protein

  1990cited by this paper
• Cytochrome oxidase deficiency affecting the structure of the myofibre and the shape of mitochondrial cristae membrane.

  1990cited by this paper
• Role of free radicals and catalytic metal ions in human disease: an overview.

  1990cited by this paper
• Localization and partial characterization of ADP-ribosylation products in hearts from adult and neonatal rats.

  1990cited by this paper
• Unesterified long-chain fatty acids inhibit thyroid hormone binding to the nuclear receptor. Solubilized receptor and the receptor in cultured cells.

  1989cited by this paper
• Free radicals and myocardial ischemia and reperfusion injury.

  1987cited by this paper
• Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.

  1982cited by this paper
• Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation.

  1981cited by this paper
• 4 Lactate Dehydrogenase

  1975cited by this paper
• Glutamate-Oxaloacetate Transaminase

  1965cited by this paper

• Biochemical Insights into the Effects of a Small Molecule Drug Candidate on Imatinib-Induced Cardiac Inflammation

  2025cites this paper
• Impacts of PACAP 1-38 and BGP-15 on the Healing of Fasciocutaneous Groin Flaps Affected by Ischemia–Reperfusion in Rats

  2025cites this paper
• Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer

  2025cites this paper
• Small Molecules Targeting HSF1 Pathway: Chemical Strategies and Therapeutic Potential.

  2025cites this paper
• BGP-15 alleviates LPS-induced depression-like behavior by promoting mitophagy.

  2024cites this paper
• Electroretinographical Analysis of the Effect of BGP-15 in Eyedrops for Compensating Global Ischemia–Reperfusion in the Eyes of Sprague Dawley Rats

  2024cites this paper
• Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis.

  2023cites this paper
• Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track

  2023cites this paper
• Mitochondrial quality control in cardiac fibrosis: Epigenetic mechanisms and therapeutic strategies.

  2023cites this paper
• PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

  2023cites this paper
• Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats

  2023influential citation
• BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function

  2023cites this paper
• Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: Extended Mitochondrial Longevity

  2022cites this paper
• Modulation of Mitochondrial Quality Control Processes by BGP-15 in Oxidative Stress Scenarios: From Cell Culture to Heart Failure

  2021cites this paper
• Pharmacological Overview of the Drug Candidate BGP-15

  2021cites this paper
• Synthesis and antifungal activity of new O-alkylamidoximes

  2021cites this paper
• Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target

  2021cites this paper
• BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats

  2021cites this paper
• Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment

  2021cites this paper
• Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome

  2020influential citation
• Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone

  2020cites this paper
• Negative Inotropic Effect of BGP-15 on the Human Right Atrial Myocardium

  2020cites this paper
• Mitochondria-targeted therapeutics, MitoQ and BGP-15, reverse aging-associated meiotic spindle defects in mouse and human oocytes

  2020cites this paper
• Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options

  2020cites this paper
• Cul4a as a New Interaction Protein of PARP1 Inhibits Oxidative Stress-Induced H9c2 Cell Apoptosis

  2019cites this paper
• Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15

  2018cites this paper
• Cardioprotective effect of KR-33889, a novel PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cells and isolated rat hearts

  2017cites this paper
• BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice

  2017cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1368 Muscle Wasting in a Rat ICU Model Underlying Mechanisms and Specific Intervention Strategies

  2017cites this paper
• Chemotherapy-Induced Gastrointestinal Dysfunction and Enteric Neuropathy

  2017cites this paper
• BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia

  2017cites this paper
• Acrolein Can Cause Cardiovascular Disease: A Review

  2017cites this paper
• Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors

  2017cites this paper
• Cardioprotective effect of KR-33889, a novel PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cells and isolated rat hearts

  2017cites this paper
• PARP inhibition and postinfarction myocardial remodeling.

  2016cites this paper
• Repurposing Drugs to Target the Diabetes Epidemic.

  2016cites this paper
• Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy

  2016cites this paper
• The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication.

  2016cites this paper
• Progress in Lipid Research

  2015cites this paper
• PARP Enzymes are Potential Targets for Cancer Chemotherapy

  2015cites this paper
• Critical illness myopathy : understanding different effects on muscle fibre function

  2015cites this paper
• Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment.

  2015cites this paper
• The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

  2014cites this paper
• The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.

  2014cites this paper
• Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes

  2014cites this paper
• Plasma membranes as heat stress sensors: from lipid-controlled molecular switches to therapeutic applications.

  2014cites this paper
• Chaperoning to the metabolic party

  2014cites this paper
• Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury

  2014cites this paper
• Synthesis of stable aromatic and heteroaromatic sulfonyl-amidoximes and evaluation of their antioxidant and lipid peroxidation activity.

  2014cites this paper
• Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies

  2014cites this paper
• The design, synthesis, and antioxidant activity of amphiphilic oximes and amidoximes.

  2013cites this paper
• Continuous Inhibition of Poly(ADP-ribose) Polymerase Does Not Reduce Reperfusion Injury in Isolated Rat Heart

  2013cites this paper
• Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustness.

  2013cites this paper
• New Chiral Aminoamidoximes: Syntheses and Investigation of Heterocyclic Compounds

  2012cites this paper
• A Novel Insulin Sensitizer Drug Candidate—BGP-15—Can Prevent Metabolic Side Effects of Atypical Antipsychotics

  2012cites this paper
• BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases

  2012cites this paper
• Protective Effect of Ischemic Postconditioning against Ischemia Reperfusion-Induced Myocardium Oxidative Injury in IR Rats

  2012cites this paper
• Heat shock hits muscular dystrophy

  2012cites this paper
• Composition pharmaceutique pour le traitement de cellules souches

  2012cites this paper
• Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts

  2011cites this paper
• Significance of the mitochondrial permeability transition in the regulation of cell death

  2011cites this paper
• BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury.

  2010cites this paper
• Necrosis: Molecular Mechanisms and Physiological Roles

  2009cites this paper
• New poly(ADP-ribose) polymerase-1 inhibitors with antioxidant activity based on 4-carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine nitroxides and their precursors.

  2009cites this paper
• Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.

  2007cites this paper
• A poly(ADP-ribose) synthetase inhibitor, benzamide protects smooth muscle cells but not endothelium against ischemia/reperfusion injury in isolated guinea-pig heart.

  2007cites this paper
• PLATELET AGGREGATION AND VISCOSITY MEASUREMENTS IN THE CLINICAL PRACTICE AND IN BASIC RESEARCH

  2007cites this paper
• Preventing apoptotic cell death by a novel small heat shock protein.

  2007cites this paper
• Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

  2007influential citation
• Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts.

  2006cites this paper
• Influence of BGP-15, a nicotinic amidoxime derivative, on the vascularization and growth of murine hepatoma xenografts.

  2006cites this paper
• Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.

  2006cites this paper
• Participation of vanilloid/capsaicin receptors, calcitonin-gene-related peptide and substance P in gastric protection of omeprazole and omeprazole-like compounds

  2006cites this paper
• Cardioprotective effects of poly(ADP-ribose) polymerase inhibition.

  2005cites this paper
• Ischemia/reperfusion injury at the intersection with cell death.

  2005cites this paper
• Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.

  2004cites this paper
• Effect of PARP-1 Inhibitors on LPS-induced in Flammation in Mice

  2004cites this paper
• Poly(ADP-ribose) polymerase activation in the reperfused myocardium.

  2004cites this paper
• Hemorheological methods in drug research

  2004cites this paper
• Impact of a novel cardioprotective agent on the ischaemia-reperfusion-induced Akt kinase activation.

  2003cites this paper
• Poly(ADP-ribose) polymerase inhibitors.

  2003cites this paper
• Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock.

  2003cites this paper
• Oxidative stress and regional ischemia-reperfusion injury: the peroxynitrite–poly(ADP-ribose) polymerase connection

  2003cites this paper
• BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats.

  2003cites this paper
• Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage.

  2003cites this paper
• Bimoclomol elevates heat shock protein 70 and cytoprotects rat neonatal cardiomyocytes.

  2002cites this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cites this paper
• Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor.

  2002cites this paper
• New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

  2002cites this paper
• Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats.

  2002cites this paper
• Medicinal chemistry of nicotinamide in the treatment of ischemia and reperfusion.

  2002cites this paper
• Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.

  2002cites this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cites this paper
• BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity.

  2002cites this paper
• Myocardial Ischemia-reperfusion Injury: Role of the Peroxynitrite-poly(ADP-ribose) Polymerase Pathway

  2002cites this paper
• Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.

  2001influential citation
• Molecular targets for pharmacological cytoprotection.

  2001cites this paper
• A short synthesis of the parp inhibitor 2-(4-trifluoro-methylphenyl)benzimidazole-4-carboxamide (NU1077)

  2001cites this paper
• Suppression of poly (ADP‐ribose) polymerase activation by 3‐aminobenzamide in a rat model of myocardial infarction: long‐term morphological and functional consequences

  2001cites this paper